Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Pepsinogen II (PGII) antibody
| Antigen | Pepsinogen II (PGII) |
| Clonality | Monoclonal (L10CC10) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human |
| Application |
Alternatives Immunohistochemistry (IHC), Western Blotting (WB), ELISA |
![]() |
8 references available |
| Catalog no. | ABIN108410 |
| Quantity | 100 ug |
| Price | 859.19 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 9 Business Day(s) |
Additional Information
| Alternative name | Pepsinogen II |
| Immunogen |
Pepsinogen II purified from human tissue was used as an immunogen. |
| Format | Purified |
| Isotype | IgG1 |
| Clone | L10CC10 |
| Description | Monoclonal Antibody to Human Gastric Biomarkers |
| Specificity | The antibody is specific to human pepsinogen II with no crossreactivity to human pepsinogen I. |
Application Details
| Application Notes | Reactivity with paraffin sections |
| Storage | This product should be stored at +2 C to +8 C |
| Research Area | Proteases |
| Restrictions | For Research Use only |
Publications
|
Varis K, Samloff IM, Ihamaki T et al.: "An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia." in: Dig Dis Sci, Vol. 24, Issue 3, pp. 187-91, 1979 (PubMed).
Farinati F, Di Mario F, Plebani M et al.: "Pepsinogen A/pepsinogen C or pepsinogen A multiplied by gastrin in the diagnosis of gastric cancer?" in: Ital J Gastroenterol, Vol. 23, Issue 4, pp. 194-6, 1991 (PubMed). Sipponen P, Kekki M, Haapakoski J et al.: "Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data." in: Int J Cancer, Vol. 35, Issue 2, pp. 173-7, 1985 (PubMed). Kikuchi S, Wada O, Miki K et al.: "Serum pepsinogen as a new marker for gastric carcinoma among young adults. Research Group on Prevention of Gastric Carcinoma among Young Adults." in: Cancer, Vol. 73, Issue 11, pp. 2695-702, 1994 (PubMed). Hattori Y, Tashiro H, Kawamoto T et al.: "Sensitivity and specificity of mass screening for gastric cancer using the measurment of serum pepsinogens." in: Jpn J Cancer Res, Vol. 86, Issue 12, pp. 1210-5, 1995 (PubMed). Yoshihara M, Sumii K, Haruma K et al.: "The usefulness of gastric mass screening using serum pepsinogen levels compared with photofluorography." in: Hiroshima J Med Sci, Vol. 46, Issue 2, pp. 81-6, 1997 (PubMed). Aoki K, Misumi J, Kimura T et al.: "Evaluation of cutoff levels for screening of gastric cancer using serum pepsinogens and distributions of levels of serum pepsinogen I, II and of PG I/PG II ratios in a gastric cancer case-control study." in: J Epidemiol, Vol. 7, Issue 3, pp. 143-51, 1997 (PubMed). Yoshihara M, Sumii K, Haruma K et al.: "Correlation of ratio of serum pepsinogen I and II with prevalence of gastric cancer and adenoma in Japanese subjects." in: Am J Gastroenterol, Vol. 93, Issue 7, pp. 1090-6, 1998 (PubMed). |
|
Alternatives
Alternatives for antigen "Pepsinogen II (PGII)", type "Antibodies"
| Hosts | Mouse (7) |
| Reactivities | Human (7) |
| Applications | ELISA (7), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (2), Western Blotting (WB) (2) |




Alternatives